Citation Impact

30 standout
Sub-graph 1 of 11

Citing Papers

Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
3 intermediate papers

Works of Ivan Titov being referenced

A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
2020

Author Peers

Author Epidemiology Infectious Diseases CCICM Molecular Medicine Pharmacology Last Decade Papers Cites
Ivan Titov 52 9 26 118 91 3 144
Rubén Torres 4 70
G. Klemz 22 255
Mangzhu Zhao 7 10 1 177 17 1.3k
Alka Pareek 20 687
Takayoshi Matsubara 6 16 1 4 10 369

All Works

Loading papers...

Rankless by CCL
2026